Global Sales of Acomplia (Rimonabant, Zimulti) Edge up to $50 Million in 2nd Quarter
Net sales of diet drug Acomplia (Rimonabant, Zimulti) edged up to almost $50 million (32 million Euros) in the second quarter of 2008, according to French pharmaceutical gians Sanofi-aventis.
This marked the strongest quarter for Acomplia (Rimonabant, Zimulti) since its launch two years ago, and was aided [...]
Study: Acomplia Increases the Likelihood of Success in Quitting Smoking
Researchers at the University of Cincinnati Acomplia (rimonabant) College of Medicine presented results of one of the largest smoking cessation trials ever conducted in the United States, STRATUS-US (STudies with Rimonabant And Tobacco USe). The findings show that a new drug, rimonabant, doubled the odds of quitting smoking compared [...]
Europeans to Decide Whether to Further Restrict Diet Drug Acomplia This Week
Will diet drug Acomplia (rimonabant), taken this past year by more than 100,000 Europeans seeking to lose weight, be pulled from the European market out of concern over depressive and suicidal side-effects?
That decision will be made known July 19th following this week’s safety review by the European [...]
Encouraging Results Expected in Report June 12th on RIO-Diabetes Trial
Another round of good news about the diet–drug Acomplia (rimonabant) seems likely to be forthcoming on June 12th when researchers publicly report for the first time on results of the RIO-Diabetes trial at the American Diabetes Association’s annual scientific meeting in San Diego.
The year-long Rimonabant in [...]
UK Company Plans Trial of Diet Drug With Same Target as Acomplia (Rimonabant)
GW Pharmaceuticals Acomplia (rimonabant) , a U.K. company with an announced goal of being the global leader in prescription cannabinoid medicine, said on Jan. 30 it hopes to soon start a Phase I clinical trial of an experimental diet drug derived from cannabis.
The company said researchers [...]
2d Generic Version of Diet Pill Rimonabant (Acomplia / Zimulti) Launched in India
ond Acomplia (rimonabant) Indian pharmaceutical company, Torrent Pharmaceuticals Ltd., has announced that it also is selling a generic version of the new Sanofi-Aventis diet drug Acomplia (rimonabant) under the name Rimoslim.
The news, which attracted little attention in the West, occurred almost simultaneously with last week’s announcement by Zydus [...]
Acomplia (Rimonabant) Shows Promise
UK biopharmaceutical company Vernalis on Sept. 14th announced that a diet drug it is developing similar to Acomplia (rimonabant) , V24343, had produced “striking weight loss” in patients in two small phase I clinical trials, with one patient losing 24 pounds in just over two weeks.
The [...]
Most Significant ‘Wait Loss’ for Diet Drug Acomplia Is Loss of Sanofi’s Huge Lead
As month after month passes with no sign of imminent FDA action on diet drug rimonabant (Acomplia / Zimulti) , the most significant “wait loss” taking place is loss of the hugh lead Sanofi-Aventis once had in developing a novel approach to weight-loss based on [...]
